Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 287

1.

Enhanced tumor detection using a folate receptor-targeted near-infrared fluorochrome conjugate.

Moon WK, Lin Y, O'Loughlin T, Tang Y, Kim DE, Weissleder R, Tung CH.

Bioconjug Chem. 2003 May-Jun;14(3):539-45.

PMID:
12757377
2.

Folate-mediated tumor cell uptake of quantum dots entrapped in lipid nanoparticles.

Schroeder JE, Shweky I, Shmeeda H, Banin U, Gabizon A.

J Control Release. 2007 Dec 4;124(1-2):28-34. Epub 2007 Aug 30.

PMID:
17928088
3.

Folate receptor-specific antitumor activity of EC131, a folate-maytansinoid conjugate.

Reddy JA, Westrick E, Santhapuram HK, Howard SJ, Miller ML, Vetzel M, Vlahov I, Chari RV, Goldmacher VS, Leamon CP.

Cancer Res. 2007 Jul 1;67(13):6376-82.

4.

Improved therapeutic activity of folate-targeted liposomal doxorubicin in folate receptor-expressing tumor models.

Gabizon A, Tzemach D, Gorin J, Mak L, Amitay Y, Shmeeda H, Zalipsky S.

Cancer Chemother Pharmacol. 2010 May;66(1):43-52. doi: 10.1007/s00280-009-1132-4. Epub 2009 Sep 25.

PMID:
19779718
5.

Tumor detection using folate receptor-targeted imaging agents.

Sega EI, Low PS.

Cancer Metastasis Rev. 2008 Dec;27(4):655-64. doi: 10.1007/s10555-008-9155-6. Review.

PMID:
18523731
6.

Molecular-receptor-specific, non-toxic, near-infrared-emitting Au cluster-protein nanoconjugates for targeted cancer imaging.

Retnakumari A, Setua S, Menon D, Ravindran P, Muhammed H, Pradeep T, Nair S, Koyakutty M.

Nanotechnology. 2010 Feb 5;21(5):055103. doi: 10.1088/0957-4484/21/5/055103. Epub 2009 Dec 21.

PMID:
20023317
7.

The therapeutic efficiency of FP-PEA/TAM67 gene complexes via folate receptor-mediated endocytosis in a xenograft mice model.

Arote RB, Hwang SK, Lim HT, Kim TH, Jere D, Jiang HL, Kim YK, Cho MH, Cho CS.

Biomaterials. 2010 Mar;31(8):2435-45. doi: 10.1016/j.biomaterials.2009.11.106. Epub 2009 Dec 21.

PMID:
20022105
8.

Improvement of meta-tetra(hydroxyphenyl)chlorin-like photosensitizer selectivity with folate-based targeted delivery. synthesis and in vivo delivery studies.

Gravier J, Schneider R, Frochot C, Bastogne T, Schmitt F, Didelon J, Guillemin F, Barberi-Heyob M.

J Med Chem. 2008 Jul 10;51(13):3867-77. doi: 10.1021/jm800125a. Epub 2008 Jun 14.

PMID:
18553957
10.

Fluorine-18 click radiosynthesis and preclinical evaluation of a new 18F-labeled folic acid derivative.

Ross TL, Honer M, Lam PY, Mindt TL, Groehn V, Schibli R, Schubiger PA, Ametamey SM.

Bioconjug Chem. 2008 Dec;19(12):2462-70. doi: 10.1021/bc800356r.

PMID:
19053298
11.

A receptor-targeted near-infrared fluorescence probe for in vivo tumor imaging.

Tung CH, Lin Y, Moon WK, Weissleder R.

Chembiochem. 2002 Aug 2;3(8):784-6. No abstract available.

PMID:
12203978
12.

Folate targeting enables durable and specific antitumor responses from a therapeutically null tubulysin B analogue.

Leamon CP, Reddy JA, Vetzel M, Dorton R, Westrick E, Parker N, Wang Y, Vlahov I.

Cancer Res. 2008 Dec 1;68(23):9839-44. doi: 10.1158/0008-5472.CAN-08-2341.

13.

Folate-linked lipid-based nanoparticles for synthetic siRNA delivery in KB tumor xenografts.

Yoshizawa T, Hattori Y, Hakoshima M, Koga K, Maitani Y.

Eur J Pharm Biopharm. 2008 Nov;70(3):718-25. doi: 10.1016/j.ejpb.2008.06.026. Epub 2008 Jul 4.

PMID:
18647651
14.

Intracellular uptake and intracavitary targeting of folate-conjugated liposomes in a mouse lymphoma model with up-regulated folate receptors.

Shmeeda H, Mak L, Tzemach D, Astrahan P, Tarshish M, Gabizon A.

Mol Cancer Ther. 2006 Apr;5(4):818-24.

15.

In vivo tumor imaging using a near-infrared-labeled endostatin molecule.

Citrin D, Scott T, Sproull M, Menard C, Tofilon PJ, Camphausen K.

Int J Radiat Oncol Biol Phys. 2004 Feb 1;58(2):536-41.

PMID:
14751525
16.

A molecular receptor targeted, hydroxyapatite nanocrystal based multi-modal contrast agent.

Ashokan A, Menon D, Nair S, Koyakutty M.

Biomaterials. 2010 Mar;31(9):2606-16. doi: 10.1016/j.biomaterials.2009.11.113. Epub 2009 Dec 24.

PMID:
20035998
17.

Synthesis and preclinical evaluation of a folic acid derivative labeled with 18F for PET imaging of folate receptor-positive tumors.

Bettio A, Honer M, Müller C, Brühlmeier M, Müller U, Schibli R, Groehn V, Schubiger AP, Ametamey SM.

J Nucl Med. 2006 Jul;47(7):1153-60.

18.

Real time, noninvasive imaging and quantitation of the accumulation of ligand-targeted drugs into receptor-expressing solid tumors.

Vlashi E, Sturgis JE, Thomas M, Low PS.

Mol Pharm. 2009 Nov-Dec;6(6):1868-75. doi: 10.1021/mp900158d.

PMID:
19754150
19.

Arthritis imaging using a near-infrared fluorescence folate-targeted probe.

Chen WT, Mahmood U, Weissleder R, Tung CH.

Arthritis Res Ther. 2005;7(2):R310-7. Epub 2005 Jan 14.

20.

[Folate-poly-L-lysine-Gd-DTPA as MR contrast agent for tumor imaging via folate receptor-targeted delivery].

Yuan Z, Liu SY, Xiao XS, Zhong GR, Jiang QJ.

Zhonghua Yi Xue Za Zhi. 2007 Mar 13;87(10):673-8. Chinese.

PMID:
17553304

Supplemental Content

Support Center